Advanced parametric imaging for evaluation of Crohn’s disease using dual-energy computed tomography enterography.

Radiol Case Rep　13,P.709-712　/　2022

Impact of retroflexion in the right colon after repeated forward-view examinations.

JGH open　2,P.282-287　/　2018

Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver

Transplant Proc　50,P.3858-3862　/　2018

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.

Open Forum Infect Dis　5,P.ofy268　/　2018

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

Aliment Pharmacol Ther　48,P.1128-1137　/　2018

Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.

Oncol Lett　16,P.5275-5281　/　2018

Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression

J Virol　92,P.e01099　/　2018

Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8 + T Cell Responses

J Virol　92,P.e01099　/　2018

Screening of microRNAs for a repressor of hepatitis B virus replication

Oncotarget　9,P.29857-29868　/　2018

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

Hepatol Int　12,P.356-367　/　2018

Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.

Cancer Lett　434,P.91-100　/　2018

Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer

Hepatol Res　48,P.1081-1091　/　2018

Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection

Hepatol Res　48,P.1172-1177　/　2018

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry

Cell Chem Biol　25,P.906-915. e7　/　2018

Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells

Mol Ther　26,P.1840-1854　/　2018

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

J Gastroenterol　53,P.1276-1284　/　2018

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma

Hepatol Res　48,P.872-881　/　2018

Gut dysbiosis associated with hepatitis C virus infection

Clin Infect Dis　67,P.869-877　/　2018

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

Hepatol Int　12,P.133-142　/　2018

Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.

CPT Pharmacometrics Syst Pharmacol　7,P.384-393　/　2018

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

Hepatol Res　48,P.549-555　/　2018

Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers

Hepatol Res　97,P.170-176　/　2018

High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues

J Gastroenterol　53,P.883-889　/　2018

Antiviral therapy for hepatitis B virus during second pregnancies

J Obstet Gynaecol Res　44,P.566-569　/　2018

Late relapse after a sustained virologic response at 24 weeks after treatment with daclatasvir and asunaprevir combination therapy for chronic hepatitis c virus genotype 1b infection with liver cirrhosis

Intern Med　57,P.951-956　/　2018

Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus

Hepatol Res　48,P.E203-E212　/　2018

Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy

Clin Microbiol Infect　24,P.306. e7-306. e13　/　2018

Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease

J Gastroenterol　53,P.438-448　/　2018

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

J Gastroenterol　53,P.247-257　/　2018

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

J Gastroenterol　53,P.119-128　/　2018

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients

Hepatol Res　48,P.134-143　/　2018